INTERSTITIAL LUNG DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hydroxychloroquine study in kids with rare lung disease halted early
Disease control TerminatedThis study looked at whether hydroxychloroquine could help children with a rare lung condition called interstitial lung disease. It was a Phase 2 trial that planned to enroll 35 children, but it was stopped early. The goal was to see if the drug improved oxygen levels or breathin…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Matthias Griese • Aim: Disease control
Last updated May 26, 2026 10:25 UTC
-
Lung drug safety study in muscle disease patients ends early
Disease control TerminatedThis study looked at whether the drug nintedanib is safe and tolerable for people with a type of lung disease caused by myositis (muscle inflammation). Researchers planned to enroll adults with scarring in the lungs, but the study was stopped early after only 11 participants. The…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 19, 2026 12:01 UTC